(3)H-N(6)-cyclohexyladenosine,
N(6)-cyclohexyladenosine,
N6-cyclohexyl-adenosine,
N6-cyclohexyladenosine,
N6-Cyclohexyladenosine,
36396-99-3,
(2R,3R,4S,5R)-2-(6-(Cyclohexylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
C16H23N5O4,
N(6)-Cyclohexyladenosine,
Adenosine, N-cyclohexyl-,
CHEMBL45891,
(2R,3R,4S,5R)-2-[6-(cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
n-cyclohexyladenosine,
N-6-cyclohexyladenosine,
N6 -cyclohexyladenosine,
N6-Cyclohexylado (CHA),
n6-cyclohexyl[3h]adenosine,
Lopac0_000331,
GTPL423,
SCHEMBL145856,
SZBULDQSDUXAPJ-XNIJJKJLSA-N,
HMS3261C03,
ZINC4217017,
Tox21_500331,
4616AB,
BDBM50009552,
MFCD00036808,
PDSP1_000670,
PDSP1_001023,
PDSP1_001025,
PDSP2_000660,
PDSP2_001007,
PDSP2_001009,
AKOS016009588,
CCG-204426,
CS-5050,
LP00331,
NCGC00093771-01,
NCGC00093771-02,
NCGC00093771-03,
NCGC00093771-04,
NCGC00261016-01,
AC-27401,
AJ-48997,
HY-18939,
EU-0100331,
ST24026156,
C 9901,
SR-01000075797,
SR-01000075797-1,
2-[6-Amino-2-(2-morpholin-4-yl-ethylamino)-purin-9-yl]-5-hydroxymethyl-tetrahydro-furan-3,4-diol,
N6-cyclohexyl-adenosine,
D02JCM,
(3)H-N(6)-cyclohexyladenosine,
C16-H23-N5-O4,
CID9841284,
C027513,
cha,